Givinostat hydrochloride monohydrate

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameGivinostat hydrochloride monohydrate
Drug Alias Name盐酸吉维司他Givinostatumgivinostat盐酸吉诺司他gavinostat +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsPancreatic neuroendocrine tumors (pNET)Becker muscular dystrophySchnitzler Syndrome +[15] 
Global Approved IndicationsMuscular Dystrophy, Duchenne
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/03/21
Country/TerritoryCzechiaBelgiumBulgaria +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesItalfarmaco
China Registration ClassN/A

Develop Information

Active CompaniesItalfarmacoItalfarmaco SpaJcr Pharmaceuticals Co Ltd
Inactive CompaniesRadboud University Medical Center
Active IndicationsMyeloproliferative DisordersHepatic InsufficiencyMuscular Dystrophy, Duchenne +[4] 
Inactive IndicationsPancreatic neuroendocrine tumors (pNET)Becker muscular dystrophySchnitzler Syndrome +[11] 

Other Information

ATC CodeM09AX14
Related LinksWikipediaDrugBankKEGG